TY  - GEN
AU  - Rexhepaj,Elton
AU  - Jirstrom,Karin
AU  - O'Connor,Darran P
AU  - O'Brien,Sallyann L
AU  - Landberg,Goran
AU  - Duffy,Michael J
AU  - Brennan,Donal J
AU  - Gallagher,William M
TI  - Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
SN  - 1471-2407
PY  - 2011///0331
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Algorithms
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Breast Neoplasms
KW  - chemistry
KW  - Cell Nucleus
KW  - Chi-Square Distribution
KW  - Cytoplasm
KW  - Decision Trees
KW  - Estrogen Receptor Modulators
KW  - therapeutic use
KW  - Female
KW  - Humans
KW  - Image Interpretation, Computer-Assisted
KW  - Immunohistochemistry
KW  - Inhibitor of Apoptosis Proteins
KW  - Kaplan-Meier Estimate
KW  - Ki-67 Antigen
KW  - Microtubule-Associated Proteins
KW  - Middle Aged
KW  - Pattern Recognition, Automated
KW  - Predictive Value of Tests
KW  - Proportional Hazards Models
KW  - Receptor, ErbB-2
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Reproducibility of Results
KW  - Risk Assessment
KW  - Risk Factors
KW  - Survivin
KW  - Sweden
KW  - Tamoxifen
KW  - Time Factors
KW  - Tissue Array Analysis
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
UR  - https://doi.org/10.1186/1471-2407-10-639
ER  -